Reading Time: 4 minutes As well as all the networking, debate and new information being shared, the International Symposium on ALS/MND is also a time to celebrate achievements by
Category: Treatments
Reading Time: 2 minutes A few months ago we wrote an article about the ALS Clinical Trials Workshop which took place in Virginia, USA. Since then the Guidelines Working
Reading Time: 2 minutes Previous research in humans and zebrafish has shown that before symptoms arise in MND, early changes occur in the interneurones. This type of nerve cell
Reading Time: 2 minutes During the early stages of MND it is proposed that motor neurones are more susceptible to an imbalance of oxygen within the cells, known as
Reading Time: 2 minutes If you looked at the motor neurones of people with MND down the microscope you would see clumps of a protein called TDP-43. Researchers around
Reading Time: 2 minutes Developing disease models is important for furthering our understanding of MND and allows researchers to screen potential new drugs for a beneficial effect. Moving a
Reading Time: 2 minutes Deposits of the protein TDP-43 are found within the motor neurones in the majority of cases of MND, and are considered a pathological hallmark of
Reading Time: 3 minutes To mark International Clinical Trials Day (20 May) we reflect on the ALS Clinical Trials Guidelines workshop that took place in March. The MND Association
Reading Time: 4 minutes The recent announcement about the use of stem cells to treat a form of multiple sclerosis (MS), together with early results from the BrainStorm stem
Reading Time: 5 minutes Clinical trials determine if potential treatments are safe and aim to prove beyond reasonable doubt whether a drug is beneficial. They are therefore the gold